For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options. But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels. Two recent clinical trials led by a researcher from the Perelman School of Medicine at the University of Pennsylvania showcase the great pro...
Fuente : http://www.eurekalert.org/pub_releases/2013-09/uop...
Fuente : http://www.eurekalert.org/pub_releases/2013-09/uop...